Evaluating the Effectiveness of Intravenous Ciclosporin on Reducing Reperfusion Injury in Patients Undergoing Primary Percutaneous Intervention: a Double-blind Randomised Controlled Trial

Trial Profile

Evaluating the Effectiveness of Intravenous Ciclosporin on Reducing Reperfusion Injury in Patients Undergoing Primary Percutaneous Intervention: a Double-blind Randomised Controlled Trial

Completed
Phase of Trial: Phase II

Latest Information Update: 19 Sep 2017

At a glance

  • Drugs Ciclosporin (Primary)
  • Indications Myocardial reperfusion injury
  • Focus Therapeutic Use
  • Acronyms CAPRI
  • Most Recent Events

    • 16 Sep 2017 Status changed from active, no longer recruiting to completed.
    • 29 Mar 2017 Planned End Date changed from 1 Mar 2018 to 1 Jan 2018.
    • 29 Mar 2017 Planned primary completion date changed from 1 Jun 2017 to 1 Apr 2017.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top